Biolase
(OTC) BIOL
Biolase Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$46.03M
Net Income (TTM)
$16.04M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
BIOL News
The Fool Looks Ahead
Whoa! What Just Happened to My Stock?
The Stocks Wall Street Loves
3 Stocks Shaking the Market
Wall Street's Buy List
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biolase
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
157
CEO
John R. Beaver, CPA
Website
www.biolase.comHeadquarters
Foothill Ranch, CA 92610-2811, US
BIOL Financials
Key Financial Metrics (TTM)
Gross Margin
34%
Operating Margin
-36%
Net Income Margin
-42%
Return on Equity
-9%
Return on Capital
-1%
Return on Assets
-59%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$16.72M
Operating Income
$17.94M
EBITDA
$15.44M
Operating Cash Flow
$14.09M
Capital Expenditure
$1.31M
Free Cash Flow
$15.40M
Cash & ST Invst.
$6.57M
Total Debt
$17.91M
Biolase Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.85M
-0.7%
Gross Profit
$4.38M
+17.0%
Gross Margin
40.39%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
157
N/A
Net Income
$1.43M
+68.9%
EBITDA
$166.00K
+95.1%
Quarterly Fundamentals
Net Cash
$15.25M
-109.0%
Accounts Receivable
$3.53M
-19.6%
Inventory
$9.87M
-28.6%
Long Term Debt
$211.00K
-98.8%
Short Term Debt
$18.48M
+402.6%
Return on Assets
-58.78%
N/A
Return on Invested Capital
-1.16%
N/A
Free Cash Flow
$4.51M
-62.9%
Operating Cash Flow
$4.47M
-72.8%